Tempus AI surpasses 500 research publications

Tempus AI has reached a research milestone of over 500 research publications. In the last eight years, Tempus has invested in rigorous scientific research to validate its diagnostic offerings, while also working with biopharma and academic collaborators to publish research supported by the company’s multimodal data library. This research milestone includes published and/or acknowledged work, comprised of: 143 peer-reviewed articles, of which 106 were Tempus-authored; 291 poster presentations based on clinical and research data presented at major scientific conferences; and 31 oral presentations at scientific meetings such as the American Society of Clinical Oncology Annual Meeting, San Antonio Breast Cancer Symposium, Society for Immunotherapy of Cancer Annual Meeting, and American Heart Association’s Scientific Sessions.